MG
RCUS icon

Marex Group’s Arcus Biosciences RCUS Stock Holding History

Marex Group’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$384K Buy
+12,440
New +$307K ﹤0.01% 781
2025
Q4 		– Sell
-12,000
Closed -$163K – 1111
2025
Q3 		$163K Sell
12,000
-5,000
-29% -$52K ﹤0.01% 743
2025
Q2 		$138K Sell
17,000
-12,000
-41% -$102K ﹤0.01% 545
2025
Q1 		$228K Buy
29,000
+15,000
+107% +$174K ﹤0.01% 549
2024
Q4 		$208K Hold
14,000
– – ﹤0.01% 539
2024
Q3 		$214K Buy
14,000
+500
+4% +$7.88K ﹤0.01% 465
2024
Q2 		$206K Hold
13,500
– – 0.01% 505
2024
Q1 		$255K Buy
+13,500
New +$233K 0.01% 350

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Marex Group's RCUS Position: Q2 2026 in Review

Marex Group opened a new position in Arcus Biosciences (RCUS) in Q2 2026: 12,440 shares worth $384K. The stake represents ﹤0.01% of the portfolio and ranks #781 among its holdings. This is a return to the name: Marex Group previously reported a position in RCUS as recently as Q3 2025.

Marex Group first reported a position in RCUS in Q1 2024 and has held it in 8 quarters since. 232 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Marex Group held 12,440 shares of Arcus Biosciences worth $384K as of Q2 2026.
  • Arcus Biosciences was a new Marex Group position in Q2 2026.
  • Arcus Biosciences made up ﹤0.01% of Marex Group's portfolio in Q2 2026, its #781 holding.
  • Marex Group first reported a position in Arcus Biosciences in Q1 2024 and has held it in 8 quarters since.
  • 232 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.